Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Pediatric Transplants

Prevalence of osteonecrosis and associated risk factors in children before allogeneic BMT

Abstract

Osteonecrosis (ON) is a debilitating long-term complication of allogeneic BMT (allo-BMT), but may begin before allo-BMT in some children because of their primary disease treatment. Therefore, to estimate the prevalence and associated risk factors for ON before allo-BMT, we conducted a retrospective analysis of magnetic resonance (MR) studies of 118 children who underwent first allo-BMT at our institution between December 2000 and September 2007. Of the 118 consecutive patients, 107 (90.7%) underwent prospective MR studies irrespective of symptoms (69 males; median age at allo-BMT 12.9 years), and 11 underwent MR studies for symptoms. Among the 107 who had prospective imaging, 23 (21.5%) had ON; nearly 50% had at least 30% epiphyseal involvement. Knees were more frequently involved than were hips; severity of ON was greater in hips. ON prevalence before allo-BMT was 23.72% when all 118 patients were included in the denominator. Risk factor analysis, limited to MR studies performed irrespective of symptoms, revealed female gender (P=0.049) and age 10 years at the time of MR study (P=0.03) as significant risk factors, and primary diagnosis of lymphoid malignancies and aplastic anemia trended toward significance. ON before allo-BMT is a common occurrence in children.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Socie G, Selimi F, Sedel L, Frija J, Devergie A, Esperou BH et al. Avascular necrosis of bone after allogeneic bone marrow transplantation: clinical findings, incidence and risk factors. Br J Haematol 1994; 86: 624–628.

    Article  CAS  Google Scholar 

  2. Socie G, Cahn JY, Carmelo J, Vernant JP, Jouet JP, Ifrah N et al. Avascular necrosis of bone after allogeneic bone marrow transplantation: analysis of risk factors for 4388 patients by the Societe Francaise de Greffe de Moelle (SFGM). Br J Haematol 1997; 97: 865–870.

    Article  CAS  Google Scholar 

  3. Zadegan F, Raould A, Bizot P, Nizard R, Sedel L . Osteonecrosis after allogeneic bone marrow transplantation. Clin Orthop Relat Res 2008; 466: 287–293.

    Article  Google Scholar 

  4. Mattano L . The skeletal remains: porosis and necrosis of bone in the marrow transplantation setting. Pediatr Transplant 2003; 7 (Suppl 3): 71–75.

    Article  Google Scholar 

  5. Schulte CM, Beelen DW . Avascular osteonecrosis after allogeneic hematopoietic stem-cell transplantation: diagnosis and gender matter. Transplantation 2004; 78: 1055–1063.

    Article  Google Scholar 

  6. Enright H, Haake R, Weisdorf D . Avascular necrosis of bone: a common serious complication of allogeneic bone marrow transplantation. Am J Med 1990; 89: 733–738.

    Article  CAS  Google Scholar 

  7. Kaste SC, Shidler TJ, Tong X, Srivastava DK, Rochester R, Hudson MM et al. Bone mineral density and osteonecrosis in survivors of childhood allogeneic bone marrow transplantation. Bone Marrow Transplant 2004; 33: 435–441.

    Article  CAS  Google Scholar 

  8. Balduzzi A, Gooley T, Anasetti C, Sanders JE, Martin PJ, Petersdorf EW et al. Unrelated donor marrow transplantation in children. Blood 1995; 86: 3247–3256.

    CAS  PubMed  Google Scholar 

  9. Faraci M, Calevo MG, Lanino E, Caruso S, Messina C, Favr C et al. Osteonecrosis after allogeneic stem cell transplantation in childhood. A case-control study in Italy. Haematologica 2006; 91: 1096–1099.

    PubMed  Google Scholar 

  10. Ohzono K, Saito M, Takaoka K, Ono K, Saito S, Nishina T et al. Natural history of nontraumatic avascular necrosis of the femoral head. J Bone Joint Surg Br 1991; 73: 68–72.

    Article  CAS  Google Scholar 

  11. Nam KW, Kim YL, Yoo JJ, Koo KH, Yoon KS, Kim HJ . Fate of untreated asymptomatic osteonecrosis of the femoral head. J Bone Joint Surg Am 2008; 90: 477–484.

    Article  Google Scholar 

  12. Karimova EJ, Rai SN, Howard SC, Neel M, Britton L, Pui CH et al. Femoral head osteonecrosis in pediatric and young adult patients with leukemia or lymphoma. J Clin Oncol 2007; 25: 1525–1531.

    Article  Google Scholar 

  13. Hungerford MW, Hungerford DS, Khanuja HS, Pietryak BP, Jones LC . Survivorship of femoral revision hip arthroplasty in patients with osteonecrosis. J Bone Joint Surg Am 2006; 88 (Suppl 3): 126–130.

    PubMed  Google Scholar 

  14. Milner PF, Kraus AP, Sebes JI, Sleeper LA, Dukes KA, Embury SH et al. Sickle cell disease as a cause of osteonecrosis of the femoral head. N Engl J Med 1991; 325: 1476–1481.

    Article  CAS  Google Scholar 

  15. Akinyoola AL, Adediran IA, Asaleye CM . Avascular necrosis of the femoral head in sickle cell disease in Nigeria: a retrospective study. Niger Postgrad Med J 2007; 14: 217–220.

    CAS  PubMed  Google Scholar 

  16. Niinimaki RA, Harila-Saari AH, Jartti AE, Seuri RM, Riikonen PV, Paakko EL et al. High body mass index increases the risk for osteonecrosis in children with acute lymphoblastic leukemia. J Clin Oncol 2007; 25: 1498–1504.

    Article  Google Scholar 

  17. Ojala AE, Paakko E, Lanning FP, Lanning M . Osteonecrosis during the treatment of childhood acute lymphoblastic leukemia: a prospective MRI study. Med Pediatr Oncol 1999; 32: 11–17.

    Article  CAS  Google Scholar 

  18. Mattano Jr LA, Sather HN, Trigg ME, Nachman JB . Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group. J Clin Oncol 2000; 18: 3262–3272.

    Article  Google Scholar 

  19. Marker DR, Seyler TM, McGrath MS, Delanois RE, Ulrich SD, Mont MA . Treatment of early stage osteonecrosis of the femoral head. J Bone Joint Surg Am 2008; 90: 175–187.

    Article  Google Scholar 

  20. Hernigou P, Galacteros F, Bachir D, Goutallier D . Deformities of the hip in adults who have sickle-cell disease and had avascular necrosis in childhood. A natural history of fifty-two patients. J Bone Joint Surg Am 1991; 73: 81–92.

    Article  CAS  Google Scholar 

  21. Karimova EJ, Rai SN, Ingle D, Ralph AC, Deng X, Neel MD et al. MRI of knee osteonecrosis in children with leukemia and lymphoma: part 2, clinical and imaging patterns. AJR Am J Roentgenol 2006; 186: 477–482.

    Article  Google Scholar 

  22. Centers for Disease Control and Prevention. CDC Criteria. Available from: www.cdc.gov/healthyweight/assessing/bmi/childrens_bmi/about_childrens_bmi.html.

  23. Hungerford DS, Jones LC . Asymptomatic osteonecrosis: should it be treated? Clin Orthop Relat Res 2004; 429: 124–130.

    Article  Google Scholar 

  24. Wheeler MD . Physical changes of puberty. Endocrinol Metab Clin North Am 1991; 20: 1–14.

    Article  CAS  Google Scholar 

  25. Shirtcliff EA, Dahl RE, Pollak SD . Pubertal development: correspondence between hormonal and physical development. Child Dev 2009; 80: 327–337.

    Article  Google Scholar 

  26. Laroche M . Intraosseous circulation from physiology to disease. Joint Bone Spine 2002; 69: 262–269.

    Article  Google Scholar 

  27. Park J, Jun J, Kim Y, Lee J, Kim C, Hahn S . Osteonecrosis of the hip in patients with aplastic anemia. J Korean Med Sci 2002; 17: 806–810.

    Article  Google Scholar 

  28. Arico M, Boccalatte MF, Silvestri D, Barisone E, Messina C, Chiesa R et al. Osteonecrosis: an emerging complication of intensive chemotherapy for childhood acute lymphoblastic leukemia. Haematologica 2003; 88: 747–753.

    CAS  PubMed  Google Scholar 

  29. Kadan-Lottick NS, Dinu I, Wasilewski-Masker K, Kaste S, Meacham LR, Mahajan A et al. Osteonecrosis in adult survivors of childhood cancer: a report from the childhood cancer survivor study. J Clin Oncol 2008; 26: 3038–3045.

    Article  Google Scholar 

  30. Marsh JC, Zomas A, Hows JM, Chapple M, Gordon-Smith EC . Avascular necrosis after treatment of aplastic anaemia with antilymphocyte globulin and high-dose methylprednisolone. Br J Haematol 1993; 84: 731–735.

    Article  CAS  Google Scholar 

  31. Shim K, MacKenzie MJ, Winquist E . Chemotherapy-associated osteonecrosis in cancer patients with solid tumours: a systematic review. Drug Saf 2008; 31: 359–371.

    Article  CAS  Google Scholar 

  32. Niinimaki RA, Harila-Saari AH, Jartti AE, Seuri RM, Riikonen PV, Paakko EL et al. Osteonecrosis in children treated for lymphoma or solid tumors. J Pediatr Hematol Oncol 2008; 30: 798–802.

    Article  CAS  Google Scholar 

  33. Hanif I, Mahmoud H, Pui CH . Avascular femoral head necrosis in pediatric cancer patients. Med Pediatr Oncol 1993; 21: 655–660.

    Article  CAS  Google Scholar 

  34. Kozuch P, Talpaz M, Faderl S, O’Brien S, Freireich EJ, Kantarjian H . Avascular necrosis of the femoral head in chronic myeloid leukemia patients treated with interferon-alpha: a synergistic correlation? Cancer 2000; 89: 1482–1489.

    Article  CAS  Google Scholar 

  35. Lackner H, Benesch M, Moser A, Smolle-Juttner F, Linhart W, Raith J et al. Aseptic osteonecrosis in children and adolescents treated for hemato-oncologic diseases: a 13-year longitudinal observational study. J Pediatr Hematol Oncol 2005; 27: 259–263.

    Article  Google Scholar 

  36. al-Bahar S, Pandita R, Hoffbrand AV . Bilateral osteonecrosis of the head of the femur complicating acute promyelocytic leukemia: a sequel to treatment of retinoic acid syndrome with dexamethasone. Acta Haematol 1996; 96: 88–91.

    Article  CAS  Google Scholar 

  37. Abhyankar D, Nair R, Menon H, Kapoor B, Advani S . Avascular necrosis of head of femur in a patient with acute promyelocytic leukemia. Leuk Lymphoma 2000; 37: 635–637.

    Article  CAS  Google Scholar 

  38. Relling MV, Yang W, Das S, Cook EH, Rosner GL, Neel M et al. Pharmacogenetic risk factors for osteonecrosis of the hip among children with leukemia. J Clin Oncol 2004; 22: 3930–3936.

    Article  Google Scholar 

  39. Niinimaki RA, Harila-Saari AH, Jartti AE, Seuri RM, Riikonen PV, Paakko EL et al. Osteonecrosis in children treated for lymphoma or solid tumors. J Pediatr Hematol Oncol 2008; 30: 798–802.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported in part by Grant number P30 CA-21765 from the National Institutes of Health, a Center of Excellence grant from the State of Tennessee and the American Lebanese Syrian Associated Charities (ALSAC). We also thank Vani J Shanker and Cherise Guess for editing the manuscript, Sandra Gaither for manuscript preparation and the physicians and nursing staff for providing outstanding clinical care to the patients in this study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S C Kaste.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sharma, S., Yang, S., Rochester, R. et al. Prevalence of osteonecrosis and associated risk factors in children before allogeneic BMT. Bone Marrow Transplant 46, 813–819 (2011). https://doi.org/10.1038/bmt.2010.210

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2010.210

Keywords

This article is cited by

Search

Quick links